Exousia Bio (LMMY) Cash from Financing Activities (2022 - 2025)
Lamy (LMMY) has disclosed Cash from Financing Activities for 4 consecutive years, with $21.9 million as the latest value for Q4 2025.
- Quarterly Cash from Financing Activities rose 25380.85% to $21.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.0 million through Nov 2025, up 26338.61% year-over-year, with the annual reading at $3500.0 for FY2025, 38.13% down from the prior year.
- Cash from Financing Activities hit $21.9 million in Q4 2025 for Lamy, up from -$3500.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $21.9 million in Q4 2025 to a low of -$86538.0 in Q4 2024.
- Historically, Cash from Financing Activities has averaged $1.7 million across 4 years, with a median of $1416.0 in 2024.
- Biggest five-year swings in Cash from Financing Activities: tumbled 6220.08% in 2024 and later soared 25380.85% in 2025.
- Year by year, Cash from Financing Activities stood at $4296.0 in 2022, then crashed by 67.09% to $1414.0 in 2023, then crashed by 6220.08% to -$86538.0 in 2024, then skyrocketed by 25380.85% to $21.9 million in 2025.
- Business Quant data shows Cash from Financing Activities for LMMY at $21.9 million in Q4 2025, -$3500.0 in Q3 2025, and $3500.0 in Q2 2025.